Tab Application Banner
  • Users Online: 785
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
 
REVIEW ARTICLE
Ahead of Print

Juvenile dermatomyositis: Controversies and recent developments in management


1 Advanced Pediatrics Centre, Allergy Immunology Unit, Postgraduate Institute of Medical Education and Research, Chandigarh, India
2 Department of Pediatrics and Chief, Advanced Pediatrics Center, Allergy Immunology Unit, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Correspondence Address:
Surjit Singh,
Department of Pediatrics and Chief, Advanced Pediatrics Center, Allergy Immunology Unit, Postgraduate Institute of Medical Education and Research, Chandigarh - 160 012
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/injr.injr_107_20

Juvenile dermatomyositis (JDM) is an autoimmune disorder of childhood that mainly affects the skin and muscles. As compared to adults, children are more likely to suffer from disease relapses and long-term complications such as lipodystrophy, insulin resistance, calcinosis, and systemic vasculopathy. There have been significant advancements in our understanding of the pathophysiology, disease course and complications of JDM in the last two decades. Due to scarcity of clinical trials in JDM, therapeutic decisions in every patient with JDM remain a challenge. This review aims to provide a comprehensive overview of the controversies, challenges in clinical management and latest advances in treatment regimens of JDM.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Chaudhary H
    -  Loganathan SK
    -  Singh S
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed48    
    PDF Downloaded7    

Recommend this journal